Opinion|Videos|February 18, 2025

Episode 3 Video: Treatment Strategies to Tackle NMIBC Heterogeneity

Author(s)Max Kates, MD, Neal Shore, MD, FACS, Jennifer A. Linehan, MD

Panelists examine disease heterogeneity in NMIBC and discuss a balanced treatment approach that prioritizes patient quality of life and surgery effectiveness.

Episodes in this series

EP. 1 Episode 1: Advancing Patient Care in Non–Muscle-Invasive Bladder Cancer

EP. 1 Episode 1: Advancing Patient Care in Non–Muscle-Invasive Bladder Cancer

EP. 2 Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

EP. 2 Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

EP. 3 Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC

EP. 3 Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC

EP. 4 Episode 3 Podcast: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 4 Episode 3 Podcast: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 5 Episode 3 Video: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 5 Episode 3 Video: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 6 Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 6 Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 7 Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 7 Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Managing BPH Before Prostate Radiotherapy: Options Compared

ByAurelie Garant, MD,Daniel Welchons, MD

September 14th 2026

Patient Selection and Partnership in Prostate Radiotherapy Spacing

ByAurelie Garant, MD,Daniel Welchons, MD

September 14th 2026

Referral Pathways and Unmet Needs in Perioperative MIBC Care

ByJoshua J. Meeks, MD, PhD

September 4th 2026

MIBC Treatment Timeline and Skin Toxicity: What Urologists Should Know

ByJoshua J. Meeks, MD, PhD

September 4th 2026

What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed

ByJoshua J. Meeks, MD, PhD

September 4th 2026

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

Managing BPH Before Prostate Radiotherapy: Options Compared

Patient Selection and Partnership in Prostate Radiotherapy Spacing

PSMA-targeted CD28 bispecific enters phase 1 trial in mCRPC

Andrew Peterson, MD, discusses advances in artificial urinary sphincter technology